Haruskah pemerintah federal diizinkan untuk menegosiasikan harga obat untuk Medicare?
The government should be allowed to negotiate with drugs that strictly used for medicinal purposes,…
I see where you're coming from, but let's not lose sight of the fact that the federal government's involvement in negotiating drug prices, medicinal cannabis included, could potentially stifle innovation and competition in the pharmaceutical industry. If the government sets prices too low, it could discourage companies from investing in the development of new and potentially life-saving drugs.
For example, consider the development of the Hepatitis C cure. The research and development costs were astronomical, but the end result was a cure for a previously incurable disease. If the government had been in charge of negotiating prices, would such a breakthrough have occurred?
Of course, it's essential to ensure medications are affordable and accessible. But it's equally important to encourage innovation in the industry. How would you propose we strike that balance?
Jadilah yang pertama membalas pertentangan ini.